Related Experiment Video
Updated: Jun 27, 2026
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Suppression of parathyroid hormone production in vitro and in vivo by RNA interference
Genta Kanai1, Takatoshi Kakuta, Kaichiro Sawada
1The Department of Medicine, Division of Nephrology and Metabolism, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Abstract:
We used RNA interference, which causes sequence-specific degradation of target mRNAs to suppress the production of parathyroid hormone by cells of patients with secondary hyperparathyroidism in vitro and in vivo. Transfection of small interfering RNA (siRNA) against human parathyroid hormone into monolayers of parathyroid cells cultured from these patients caused a dose-dependent decrease of secretion and mRNA levels with 80% or more suppression using 40 nM siRNA. Parathyroid cells cultured on non-adherent plastic produced spheroid cell aggregates which secreted parathyroid hormone for more than 150 days. Transfection of these spheroids with 50 nM targeted siRNA decreased parathyroid hormone production to 20% of the control level, with half of them being suppressed for 50 days. When parathyroid cells were transplanted into the livers of athymic nude mice, plasma human parathyroid hormone rose to 100-300 pg/ml within one month and remained at about this level for at least 39 days. Systemic delivery of hormone-targeted siRNA into these mice caused a dose-dependent suppression of circulating human parathyroid hormone for at least one month, with a maximum 80% suppression achieved by 80 microg of siRNA. Our study shows that hormone secretion by parathyroid cells of patients with secondary hyperparathyriodism can be suppressed both in vitro and in vivo by targeted siRNAs.
Insights
Small interfering RNA (siRNA) effectively suppresses parathyroid hormone production in cells from secondary hyperparathyroidism patients. This RNA interference therapy shows promise for both in vitro and in vivo treatment applications.
Area of Science:
- Endocrinology
- Molecular Biology
- RNA Therapeutics
Background:
- Secondary hyperparathyroidism is characterized by excessive parathyroid hormone (PTH) production.
- Current treatments for secondary hyperparathyroidism have limitations.
- RNA interference offers a novel approach to target specific gene expression.
Purpose of the Study:
- To investigate the efficacy of small interfering RNA (siRNA) in suppressing parathyroid hormone (PTH) production in vitro and in vivo.
- To evaluate targeted siRNA delivery for treating secondary hyperparathyroidism.
Main Methods:
- Utilized RNA interference (RNAi) to degrade target messenger RNA (mRNA) for PTH.
- Transfected parathyroid cells and spheroid aggregates with PTH-targeted siRNA.
- Transplanted human parathyroid cells into athymic nude mice and assessed systemic siRNA delivery.
Main Results:
- In vitro: 40 nM siRNA achieved >80% suppression of PTH secretion and mRNA levels.
- In vitro spheroids: 50 nM siRNA reduced PTH production to 20% of control for 50 days.
- In vivo: Systemic siRNA delivery achieved up to 80% dose-dependent suppression of circulating PTH for over a month.
Conclusions:
- Targeted siRNAs can effectively suppress PTH secretion from patient-derived parathyroid cells.
- RNA interference demonstrates therapeutic potential for managing secondary hyperparathyroidism in both laboratory and animal models.
- This study validates siRNA as a viable strategy for controlling excessive hormone production in endocrine disorders.
Related Concept Videos
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
00:59The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...